Both SARS-CoV-2 and DENV can promote activation of immune cells, leading to the release of proinflammatory cytokines, such as IFN, and causing capillary leakage, thrombocytopenia, and coagulopathy, pathophysiological similarities between COVID-19 and dengue (3). Here, IFNA1 is linked to COVID-19.